NEJM Evidence· 2026Q1
Metoprolol in Chronic Obstructive Pulmonary Disease without Cardiovascular Disease
- 1citations
- Q1SCImago
- 2026year
Short summary
In patients with COPD but no cardiovascular disease, metoprolol did not significantly reduce the time to a composite of COPD exacerbations, cardiovascular events, or death over 1 year (HR, 0.87; P=0.14).
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Pulmonary and Respiratory Medicine
Pulmonary and Respiratory MedicineMedicine